Search Results - "Kryda, Kristina"
-
1
Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance
Published in Parasites & vectors (11-03-2022)“…Heartworm (Dirofilaria immitis) disease continues to increase and spread, remaining one of the most important and pathogenic parasitic diseases of dogs,…”
Get full text
Journal Article -
2
A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis
Published in Veterinary dermatology (01-12-2016)“…Background Lokivetmab (ZTS‐00103289) is a caninized anti‐canine IL‐31 monoclonal antibody that has demonstrated efficacy in reducing pruritus associated with…”
Get full text
Journal Article -
3
Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA
Published in Parasites & vectors (01-03-2020)“…One randomized, controlled clinical field study was conducted in 18 general veterinary practices throughout the USA to evaluate the safety and efficacy of a…”
Get full text
Journal Article -
4
Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of Ixodes scapularis on dogs
Published in Parasites & vectors (01-03-2020)“…The black-legged (or deer) tick, Ixodes scapularis, commonly infests dogs in the USA and is the vector of important zoonotic pathogens, including Borrelia…”
Get full text
Journal Article -
5
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
Published in Parasites & vectors (26-07-2019)“…The efficacy of an extended-release injectable moxidectin (0.5 mg/kg) suspension (ProHeart® 12) (PH 12) in preventing the development of Dirofilaria immitis in…”
Get full text
Journal Article -
6
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
Published in Parasites & vectors (11-09-2019)“…Moxidectin has previously shown limited efficacy (≤ 44.4%) against confirmed macrocyclic lactone (ML)-resistant Dirofilaria immitis strains at 3 µg/kg after…”
Get full text
Journal Article -
7
Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced ascarid infections in dogs
Published in Parasites & vectors (01-03-2020)“…Ascarid infections are among the most prevalent intestinal parasitic infections occurring in dogs around the world, with Toxocara canis and Toxascaris leonina…”
Get full text
Journal Article -
8
Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs
Published in Parasites & vectors (01-03-2020)“…Ancylostomatids ('hookworms') are among the most important zoonotic nematode parasites infecting dogs worldwide. Ancylostoma caninum and Uncinaria stenocephala…”
Get full text
Journal Article -
9
A review of moxidectin vs. other macrocyclic lactones for prevention of heartworm disease in dogs with an appraisal of two commercial formulations
Published in Frontiers in veterinary science (24-06-2024)“…Macrocyclic lactones (MLs) are the only drug class currently licensed for heartworm disease prophylaxis. Macrocyclic lactones kill third- and fourth-stage…”
Get full text
Journal Article -
10
Comparative preventive efficacy of ProHeart ® 12, Heartgard ® Plus and Interceptor ® Plus against a macrocyclic lactone-resistant strain (JYD-34) of heartworm (Dirofilaria immitis) in dogs
Published in Parasites & vectors (26-04-2021)“…The current studies compared ProHeart 12, Heartgard Plus and Interceptor Plus for preventive efficacy against JYD-34, a macrocyclic lactone (ML)-resistant…”
Get full text
Journal Article -
11
Preventive efficacy of six monthly oral doses of Simparica Trio ® , Heartgard ® Plus, and Interceptor ® Plus against a macrocyclic lactone-resistant strain (ZoeLA) of heartworm (Dirofilaria immitis) in dogs
Published in Parasites & vectors (11-03-2022)“…Administration of four to six consecutive monthly doses of 24 µg/kg moxidectin alone shows high effectiveness in preventing the maturation of macrocyclic…”
Get full text
Journal Article -
12
Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA
Published in Parasites & vectors (01-03-2020)“…Gastrointestinal nematodes are parasites that commonly infect dogs, and infections can be subclinical or may cause considerable clinical disease. Some species…”
Get full text
Journal Article -
13
Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs
Published in Parasites & vectors (11-09-2019)“…Dirofilaria immitis is a filarial parasite of dogs that can cause serious or fatal cardiopulmonary disease. Three studies were conducted to evaluate the…”
Get full text
Journal Article -
14
Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of five common tick species infesting dogs in the USA
Published in Parasites & vectors (01-03-2020)“…The efficacy of a novel oral combination product, Simparica Trio™, containing sarolaner, moxidectin and pyrantel was evaluated against five tick species that…”
Get full text
Journal Article -
15
Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) for the treatment and control of flea infestations on dogs
Published in Parasites & vectors (01-03-2020)“…Five studies were conducted to evaluate a novel oral combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™), for efficacy against…”
Get full text
Journal Article -
16
Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
Published in Parasites & vectors (14-07-2020)“…Recent reports indicated that increasing the monthly oral dosage and the number of consecutive monthly doses of moxidectin improved the efficacy against…”
Get full text
Journal Article -
17
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart ® 12) in dogs
Published in Parasites & vectors (06-09-2019)“…The safety of ProHeart® 12 (PH 12; extended-release injectable suspension; 10% moxidectin in glyceryl tristearate microspheres) was evaluated in four studies…”
Get full text
Journal Article -
18
Insecticidal activity of Simparica and Simparica Trio against Aedes aegypti in dogs
Published in Parasites & vectors (09-03-2023)“…Aedes aegypti is one of the main species responsible for the transmission of mosquito-borne pathogens worldwide. The isoxazoline Sarolaner has excellent…”
Get full text
Journal Article -
19
Preventive efficacy of six monthly oral doses of Simparica Trio[R], Heartgard[R] Plus, and Interceptor[R] Plus against a macrocyclic lactone-resistant strain in dogs
Published in Parasites & vectors (11-03-2022)“…Administration of four to six consecutive monthly doses of 24 [micro]g/kg moxidectin alone shows high effectiveness in preventing the maturation of macrocyclic…”
Get full text
Journal Article -
20
Comparative preventive efficacy of ProHeart[R] 12, Heartgard[R] Plus and Interceptor[R] Plus against a macrocyclic lactone-resistant strain in dogs
Published in Parasites & vectors (26-04-2021)“…The current studies compared ProHeart.sup.[R] 12, Heartgard.sup.[R] Plus and Interceptor.sup.[R] Plus for preventive efficacy against JYD-34, a macrocyclic…”
Get full text
Journal Article